mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope.
Saved in:
| Title: | mAbClust with AlphaFold 3 avoids hallucinations to define a quaternary broadly neutralizing HCV epitope. |
|---|---|
| Authors: | Paul HT; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. USA., Mimms JL; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. USA., Aboueid H; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. USA., Buitrago LS; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. USA., Kulakova L; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA., Wilcox X; Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA., Kuhn K; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. USA., Zhang H; Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA., Toth EA; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA., Skinner N; The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH 43205, USA.; Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA., Flyak AI; Department of Microbiology and Immunology, Cornell University, Ithaca, NY, USA., Ofek G; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 20742, USA., Benjamin Larman H; Institute for Cell Engineering, Division of Immunology, Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA., Fuerst TR; Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, 20742, USA., Ray SC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Cox AL; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. USA.; Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Bailey JR; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. USA.; Department of Molecular Microbiology and Immunology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2026 Jan 07. Date of Electronic Publication: 2026 Jan 07. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
